Multimodal Identification of Depressive Symptoms in the Elderly
Launched by WUHAN MENTAL HEALTH CENTRE · Aug 5, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to better identify signs of depression in older adults. Instead of just using traditional questionnaires, the study will use artificial intelligence (AI) to look at multiple types of information at once—like facial expressions, voice, the words people use, and body movements. By combining all these clues, the researchers hope to create a more accurate tool for recognizing depression, which can sometimes be missed or misunderstood with current methods.
The study is looking for participants who are 60 years or older and live in the community (not in hospitals or care homes) for at least six months. Participants need to be able to read, write, and understand instructions well enough to communicate with the researchers and complete the study tasks. People who have serious illnesses, dementia, are currently taking antidepressants, or have had recent suicidal thoughts will not be eligible. If you join, you can expect to take part in assessments that may involve talking, answering questions, and possibly having your facial expressions and movements observed. This study isn’t recruiting yet, but if you’re interested, it’s important to know that it aims to improve how depression is detected in older adults using new technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elderly individuals aged 60 years or older.
- • Residents of the community (with residence time of more than 6 months).
- • Possessing certain reading, writing and comprehension skills, being able to communicate with researchers without obstacles, and being able to independently complete the measurement of various indicators or, although unable to independently fill out the questionnaire, being able to independently make evaluations of the questionnaire items.
- • Those who have given informed consent.
- Exclusion Criteria:
- • Those who meet the diagnostic criteria for cognitive impairment (dementia) as stipulated in DSM-5, and/or who suffer from severe physical diseases (such as advanced cancer, cardiovascular and cerebrovascular diseases, etc.).
- • Those who are undergoing antidepressant treatment.
- • Elderly individuals who have had suicidal thoughts in any psychological assessment, should be referred to the psychological hotline platform in Wuhan.
About Wuhan Mental Health Centre
Wuhan Mental Health Centre is a leading clinical research institution dedicated to advancing mental health care through innovative research and evidence-based practices. With a focus on developing and evaluating novel therapeutic interventions, the Centre collaborates with healthcare professionals and academic institutions to conduct rigorous clinical trials aimed at improving treatment outcomes for individuals with various mental health disorders. Committed to fostering a compassionate and supportive environment, the Centre prioritizes patient safety and ethical standards while contributing to the global understanding of mental health through its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
Xiaoxv Yin, PhD
Study Chair
Huazhong University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported